Regulatory Open Forum

 View Only
Reg Intel Conference 2024
Back to discussions
Expand all | Collapse all

Japan’s national health insurance will hear objections to drug price revisions

  • 1.  Japan’s national health insurance will hear objections to drug price revisions

    Posted 05-Aug-2020 16:32
    With the COVID-19 pandemic cutting deeply into revenues of healthcare providers across Japan, health authorities are considering postponing cuts to prices for pharmaceuticals offered by the country’s nationalized health insurance system scheduled to go into effect next April. The scheduled price cuts are designed to address large gaps between prices for those products offered by Japan’s National Health Insurance system and market prices. But some manufacturers and wholesalers contend that implementing the price cuts in 2021 would put additional burden on an industry that is already strained. Japan’s Ministry of Health, Labor, and Welfare (MHLW) plans to hold hearings on the issue soon.

    ------------------------------
    Ames Gross
    President
    Pacific Bridge Medical
    Bethesda, MD
    www.pacificbridgemedical.com
    contact@pacificbridgemedical.com
    ------------------------------


Related Content